BioCryst Pharmaceuticals Unveiled New Orladeyo Clinical And Real-world Data, Alongside Updated Phase 1b/2 Alpha-star Results For Investigational Hae Therapy Navenibart

Benzinga Newsdesk www.benzinga.com Neutral 71.1%

Neg 0% Neu 71.1% Pos 0%

Comments

No comments yet. Be the first!